LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases.

    Pawar, Ashish Yashwantrao / Hiray, Apoorva Prashant / Sonawane, Deepak Devidas / Bhambar, Rajendra Sudhakar / Derle, Deelip Vishram / Ahire, Yogesh Suresh

    Diabetes & metabolic syndrome

    2020  Volume 14, Issue 4, Page(s) 665–669

    Abstract: Background & aim: As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situation across the globe. ...

    Abstract Background & aim: As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situation across the globe. As per WHO guidelines, the treatment is mainly symptomatic and supportive. This clinical protocol has not proven sufficient to save the lives of COVID-19 patients suffering from diabetes or having underlying liver diseases; hence there is utmost need to tackle this situation by other means such as Convalescent Plasma (CP) therapy.
    Methods: A comprehensive literature survey was carriedout using Elsevier, PubMed, Taylor & Francis, Springer, Nature and Google search engines.
    Results: The patients suffering from diabetes or liver dysfunction or any other underlying diseases are at greatest risk of SARS-CoV-2 infection. From the study, it is proved that plasma collected from the recovered patients of viral infection has considerable potential to treat the viral disease without the occurrence of adverse effects.
    Conclusion: The CP therapy can be a possible life saving alternative to treat critical COVID-19 patients having diabetes or underlying liver dysfunction. Hence, randomised clinical trials are recommended at the earliest to save the lives of infected individuals of COVID-19.
    MeSH term(s) Betacoronavirus/immunology ; COVID-19 ; Clinical Protocols ; Comorbidity ; Coronavirus Infections/immunology ; Coronavirus Infections/therapy ; Diabetes Complications/immunology ; Diabetes Complications/physiopathology ; Diabetes Complications/therapy ; Humans ; Immunization, Passive ; Liver Diseases/complications ; Liver Diseases/immunology ; Liver Diseases/physiopathology ; Liver Diseases/therapy ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/therapy ; Randomized Controlled Trials as Topic ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-05-12
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2273766-2
    ISSN 1878-0334 ; 1871-4021
    ISSN (online) 1878-0334
    ISSN 1871-4021
    DOI 10.1016/j.dsx.2020.05.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

    Pawar, Ashish Yashwantrao / Hiray, Apoorva Prashant / Sonawane, Deepak Devidas / Bhambar, Rajendra Sudhakar / Derle, Deelip Vishram / Ahire, Yogesh Suresh

    Diabetes Metab Syndr

    Abstract: BACKGROUND & AIM: As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situation across the globe. ... ...

    Abstract BACKGROUND & AIM: As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situation across the globe. As per WHO guidelines, the treatment is mainly symptomatic and supportive. This clinical protocol has not proven sufficient to save the lives of COVID-19 patients suffering from diabetes or having underlying liver diseases; hence there is utmost need to tackle this situation by other means such as Convalescent Plasma (CP) therapy. METHODS: A comprehensive literature survey was carriedout using Elsevier, PubMed, Taylor & Francis, Springer, Nature and Google search engines. RESULTS: The patients suffering from diabetes or liver dysfunction or any other underlying diseases are at greatest risk of SARS-CoV-2 infection. From the study, it is proved that plasma collected from the recovered patients of viral infection has considerable potential to treat the viral disease without the occurrence of adverse effects. CONCLUSION: The CP therapy can be a possible life saving alternative to treat critical COVID-19 patients having diabetes or underlying liver dysfunction. Hence, randomised clinical trials are recommended at the earliest to save the lives of infected individuals of COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #232720
    Database COVID19

    Kategorien

  3. Article ; Online: Convalescent plasma

    Pawar, Ashish Yashwantrao / Hiray, Apoorva Prashant / Sonawane, Deepak Devidas / Bhambar, Rajendra Sudhakar / Derle, Deelip Vishram / Ahire, Yogesh Suresh

    Diabetes & Metabolic Syndrome: Clinical Research & Reviews

    A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

    2020  Volume 14, Issue 4, Page(s) 665–669

    Keywords Internal Medicine ; Endocrinology, Diabetes and Metabolism ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2273766-2
    ISSN 1878-0334 ; 1871-4021
    ISSN (online) 1878-0334
    ISSN 1871-4021
    DOI 10.1016/j.dsx.2020.05.023
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top